Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

1 article from the last 30 days matching "Infarction"

GrantNIH REPORTERMay 11

New NIH Grant: Development of a rapid enzymatic assay for point-of-care HIV drug level feedback — $670K at Unknown Institution

Researchers are getting $670,000 to develop a quick test that measures HIV medication levels in the blood. This test would help doctors and patients know if HIV medicines are working well by checking if patients are taking them correctly. The project focuses on helping teenage girls and young women in Africa, where HIV is a major health problem.

WHY IT MATTERSThis tool could help HIV-positive adolescents and young women in sub-Saharan Africa know whether their medication levels are adequate for treatment and prevention, addressing a critical adherence challenge in a population accounting for one in four new global HIV infections.
👁 Watch this spaceHIV infection

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases